A Randomized Controlled Trial of Short-Term Versus Long-Term Prophylactic Intravesical Instillation Chemotherapy for Recurrence After Transurethral Resection of Ta/T1 Transitional Cell Carcinoma of the Bladder-Reference-Cited by-同舟云学术

A Randomized Controlled Trial of Short-Term Versus Long-Term Prophylactic Intravesical Instillation Chemotherapy for Recurrence After Transurethral Resection of Ta/T1 Transitional Cell Carcinoma of the Bladder

Published:2004-01 Issue:1 Volume:171 Page:153-157
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

KOGA HIROFUMI¹,KUROIWA KENTARO¹,YAMAGUCHI AKITO¹,OSADA YUKIO¹,TSUNEYOSHI MASAZUMI¹,NAITO SEIJI¹

Affiliation:

1. From the Departments of Urology, Graduate School of Medical Sciences, Kyushu University (HK, KK, SN) and Harasanshin General Hospital (AY), Kyushu University Urological Oncology Group (HK, KK, AY, YO, SN), Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University (MT), Fukuoka and Department of Urology, Miyazaki Medical College, Miyazaki, Japan (YO)

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Intravesical therapy for bladder cancer;Soloway;Urol Clin N Amer,1988

2. Swedish Council of Technology Assessment in Health Care: A systematic overview of chemotherapy effects in urothelial bladder cancer;Nilsson;Acta Oncol,2001

3. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder;Lamm;N Engl J Med,1991

4. Treatment of superficial bladder cancer with intravesical chemotherapy;Badalament;Semin Surg Oncol,1997

5. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study;Ali-El-Dein;J Urol,1997

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Proliferative Effects of Lidocaine as an Autophagy Inducer in Bladder Cancer via Intravesical Instillation: In Vitro and Xenograft Mouse Model Experiments;Cancers;2024-03-24

2. The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer;BMC Cancer;2023-10-23

3. French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC);Progrès en Urologie;2022-11

4. Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer – Abridged version;Canadian Urological Association Journal;2021-08-16

5. Overexpression of replication protein A3 is associated with unfavorable outcome in bladder urothelial carcinoma;Journal of Cancer Research and Therapeutics;2021